Brian Piekos

Brian Piekos is the Chief Financial Officer of Elicio Therapeutics, Inc. Brian brings more than 25 years of experience in industry and finance to Elicio. Mr. Piekos joins the Company from Gemini Therapeutics where he was Chief Financial Officer.  Prior to joining Gemini he had been at AMAG Pharmaceuticals serving as Chief Financial Officer upon the company’s sale in November 2021. Prior to joining AMAG, he held leadership roles in Corporate Finance, Tax and Treasury at Cubist Pharmaceuticals. Mr. Piekos began his career as a healthcare investment banker at Needham & Company and Leerink Partners.

Mr. Piekos earned his MBA from the Simon Business School at the University of Rochester. He obtained an M.S. in molecular biology from the University of Massachusetts Medical School and a B.A. in biochemistry from Ithaca College.